| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ffd5528fd07384d7b07ab484ed5b143 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-60 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate |
2016-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86146b0bc371459f4a2e9f0e0e79b87b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c55d0ef58aec0d18e1c5d016025bf31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9131374855ec78d53b111deaa0dab41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_666872b84e85beacffca50ee4a7ae4d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c737d9b660f98de9e2083f07ce911e11 |
| publicationDate |
2017-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017165265-A1 |
| titleOfInvention |
Heat shock protein binding compounds, compositions, and methods for making and using same |
| abstract |
The present subject matter relates to a compound represented by the general formula (I) or (I′) or a pharmacologically acceptable salt thereof; pharmaceutical compositions containing at least one of these compounds; methods of making at least one of these compounds; methods of using at least one of these compounds for treating and/or preventing various cancers and/or proliferation disorders; methods of using at least one of these compounds for monitoring the effectiveness of an anticancer therapy against various cancers. In one embodiment, the subject matter relates to compounds that bind with a level of specificity to heat shock protein 70 (Hsp70). In another embodiment, the subject matter relates to compounds that bind with a level of specificity to inhibit both heat shock protein 70 (Hsp70) and heat shock cognate protein 70 (Hsc70). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019118734-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9878987-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10617772-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11447471-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017233352-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10160729-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10647683-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11065350-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758538-B2 |
| priorityDate |
2009-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |